Raskin Gregory S 4
4 · Y-mAbs Therapeutics, Inc. · Filed Aug 29, 2019
Insider Transaction Report
Form 4
Raskin Gregory S
Director
Transactions
- Sale
Common Stock
2019-08-29$26.70/sh−5,882$157,026→ 0 total
Footnotes (2)
- [F1]The Reporting Person has entered into a contract with Memorial Sloan Kettering Cancer Center pursuant to which the Reporting Person will contribute to Memorial Sloan Kettering Cancer Center his earnings from the interests described herein.
- [F2]This transaction was executed in multiple trades. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.